More than One-Third of Drug-Resistant Epilepsy Patients Achieved ≥90% Seizure Reduction with the RNS System. NEW ORLEANS--(BUSINESS WIRE)--American Epilepsy Society Annual Meeting, Booth 519 —…
NeuroPace Inc.December 2, 2018
WASHINGTON--(EON: Enhanced Online News)--American Epilepsy Society Annual Meeting, Booth 1101--NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop…
NeuroPace Inc.December 5, 2017
MOUNTAIN VIEW, Calif. – October 24, 2017 – NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop brain-responsive…
NeuroPace Inc.October 23, 2017
MOUNTAIN VIEW, California – February 20, 2017 – NeuroPace, Inc. announced today that the 1000th patient has been treated with its award-winning RNS® System, approved…
NeuroPace Inc.February 27, 2017
